Liver and Biliary Pathology — MCQs

Liver and Biliary Pathology Indian Medical PG Practice Questions and MCQs

Question 231: Spider nevi are due to the action of which hormone?

A. Estrogen (Correct Answer)
B. Androgen
C. Steroids
D. Progesterone

Explanation: **Explanation:** **Spider nevi** (also known as spider angiomas) are a classic cutaneous manifestation of hyperestrogenism, most commonly seen in patients with chronic liver disease (cirrhosis). **1. Why Estrogen is the Correct Answer:** In a healthy individual, the liver is responsible for the metabolism and clearance of steroid hormones. In patients with liver failure or cirrhosis, the liver's ability to metabolize **estrogen** is significantly impaired, leading to increased serum levels. Estrogen has a direct **vasodilatory effect** on precapillary sphincters. This results in the characteristic central red arteriole with radiating "legs" (capillaries) seen on the skin, typically in the distribution of the superior vena cava (face, neck, and upper chest). **2. Why Other Options are Incorrect:** * **Androgen:** In liver disease, androgens (like testosterone) are actually decreased or more rapidly converted to estrogen via peripheral aromatization. Low androgen levels contribute to feminization (e.g., loss of chest hair) but do not cause spider nevi. * **Steroids (Glucocorticoids):** Excess glucocorticoids (Cushing’s syndrome) cause skin thinning and purple striae, not spider nevi. * **Progesterone:** While progesterone levels may fluctuate in liver disease, it does not possess the potent vasodilatory properties required to form spider angiomas. **3. NEET-PG High-Yield Pearls:** * **Hyperestrogenism Triad in Cirrhosis:** Spider nevi, Palmar erythema, and Gynecomastia. * **Clinical Test:** Spider nevi exhibit **"pulsatility"**; when the central arteriole is pressed with a glass slide (diascopy) or a pinhead, the entire lesion blanches and refills from the center outward upon release. * **Other causes:** Spider nevi can also be seen in physiological states with high estrogen, such as **pregnancy** or in women taking **Oral Contraceptive Pills (OCPs)**.

Question 232: Reye's syndrome is diagnosed by using which stain?

A. Reticulin stain
B. Oil-red-O stain (Correct Answer)
C. PAS stain
D. Mustein stain

Explanation: **Explanation:** **Reye’s syndrome** is a rare but severe condition characterized by acute encephalopathy and fatty liver failure, typically following a viral illness (like Influenza or Varicella) in children treated with **aspirin (salicylates)**. The underlying pathophysiology involves **mitochondrial dysfunction**, which leads to the inhibition of fatty acid oxidation. This results in **microvesicular steatosis** (small droplets of fat within hepatocytes) without significant inflammation or necrosis. Because routine formalin fixation and paraffin embedding dissolve lipids, these microvesicles may appear as clear vacuoles or be difficult to visualize on standard H&E stains. To definitively identify these neutral lipids, frozen sections must be used and stained with **Oil-red-O** or **Sudan Black**, which highlights the fat droplets in bright red or black, respectively. **Analysis of Incorrect Options:** * **A. Reticulin stain:** Used to visualize the type III collagen framework of the liver. It is helpful in diagnosing cirrhosis or hepatic tumors (where the reticulin framework is disrupted) but does not detect fat. * **C. PAS (Periodic Acid-Schiff) stain:** Primarily used to highlight glycogen, basement membranes, and fungi. In the liver, it is specifically used to detect diastase-resistant globules in **Alpha-1 Antitrypsin deficiency**. * **D. Mustein stain:** This is likely a distractor or a misspelling of Movat’s Pentachrome or similar; it has no diagnostic relevance to Reye’s syndrome. **High-Yield NEET-PG Pearls:** * **Morphology:** Look for "Microvesicular steatosis" (also seen in Fatty Liver of Pregnancy and Valproate toxicity). * **Electron Microscopy:** Shows characteristic **"Amoeboid" (swollen) mitochondria** with loss of cristae. * **Clinical Triad:** Prior viral fever + Aspirin intake + Profuse vomiting/Altered sensorium. * **Biochemical marker:** Elevated serum ammonia and PT/PTT, but usually normal or only mildly elevated bilirubin.

Question 233: Vanishing bile duct syndrome is seen in which of the following conditions?

A. Primary sclerosing cholangitis
B. Primary biliary cirrhosis
C. Cystic fibrosis
D. All of the above (Correct Answer)

Explanation: **Explanation:** **Vanishing Bile Duct Syndrome (VBDS)** refers to a group of disorders characterized by the progressive destruction and loss of intrahepatic bile ducts (ductopenia). Histologically, it is defined as the absence of bile ducts in more than 50% of the portal tracts in a liver biopsy specimen [1]. **Why "All of the Above" is Correct:** The underlying mechanism involves chronic inflammation or genetic defects leading to the irreversible loss of small bile ducts. * **Primary Biliary Cholangitis (PBC):** Formerly called Primary Biliary Cirrhosis, this is the classic example of VBDS. It involves T-cell mediated destruction of small intrahepatic bile ducts (florid duct lesions) [1]. * **Primary Sclerosing Cholangitis (PSC):** This condition involves inflammation and "onion-skin" fibrosis of both intra- and extrahepatic bile ducts, eventually leading to ductular loss [3, 5]. * **Cystic Fibrosis:** Mutations in the CFTR gene lead to thick, inspissated secretions in the bile ducts, causing focal biliary cirrhosis and secondary ductopenia. **Other Causes of VBDS:** * **Drug-induced:** Augmentin (most common), Phenytoin, and Carbamazepine [2]. * **Graft-versus-Host Disease (GVHD):** A major cause in post-transplant patients. * **Alagille Syndrome:** A genetic cause (JAG1 mutation) leading to congenital ductopenia. **High-Yield Clinical Pearls for NEET-PG:** * **Hallmark Sign:** Progressive cholestasis (elevated Alkaline Phosphatase and GGT) with jaundice [4]. * **PBC Marker:** Anti-Mitochondrial Antibody (AMA) is positive in 95% of cases. * **PSC Association:** Strongly associated with Ulcerative Colitis (p-ANCA positive) [3, 5]. * **Biopsy Requirement:** At least 10 portal tracts must be present in a biopsy to accurately diagnose ductopenia. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 864-865. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 393-394. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 865-866.

Question 234: Vanishing bile duct syndrome is seen in which of the following conditions?

A. Chronic viral hepatitis
B. Sarcoidosis (Correct Answer)
C. Lymphoma
D. Non-cirrhotic portal fibrosis

Explanation: **Explanation:** **Vanishing Bile Duct Syndrome (VBDS)** refers to a group of disorders characterized by the progressive destruction and loss of intrahepatic bile ducts (ductopenia), leading to chronic cholestasis. **Why Sarcoidosis is correct:** Sarcoidosis is a systemic granulomatous disease. In the liver, it causes the formation of non-caseating granulomas, primarily in the portal tracts [1]. These granulomas can physically compress or immunologically destroy the small bile ducts, leading to significant ductopenia and a clinical picture of VBDS [1]. **Analysis of Incorrect Options:** * **Chronic Viral Hepatitis:** This typically presents with interface hepatitis, portal inflammation, and fibrosis [3]. While it can cause biliary scarring in late stages (cirrhosis), it is not a classic cause of primary ductopenia or VBDS. * **Lymphoma:** While Hodgkin Lymphoma is a known (though rare) cause of paraneoplastic VBDS, it is not the primary association intended in standard pathology curriculum compared to granulomatous diseases like Sarcoidosis. * **Non-cirrhotic Portal Fibrosis (NCPF):** This condition involves obliterative venopathy of the portal vein branches leading to portal hypertension. The bile ducts remain largely unaffected. **High-Yield Clinical Pearls for NEET-PG:** * **Definition of Ductopenia:** Loss of bile ducts in >50% of portal tracts (usually based on a biopsy containing at least 10 portal tracts) [2]. * **Other Causes of VBDS:** Primary Biliary Cholangitis (PBC) – *most common cause* [2], Primary Sclerosing Cholangitis (PSC), Graft-versus-Host Disease (GVHD), and Alagille Syndrome. * **Drug-induced VBDS:** Most commonly associated with Chlorpromazine, Amoxicillin-Clavulanic acid, and Carbamazepine. * **Histology Tip:** Look for "empty" portal tracts containing an artery and a vein but lacking the accompanying bile duct [2]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 401-402. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 864-865. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 391-392.

Question 235: Which of the following does not cause microvesicular steatosis?

A. Alcoholic fatty liver (Correct Answer)
B. Tetracycline toxicity
C. Acute fatty liver of pregnancy
D. Reyes syndrome

Explanation: **Explanation** The correct answer is **Alcoholic fatty liver** because it typically presents as **macrovesicular steatosis** [1]. In **macrovesicular steatosis**, a single large fat droplet fills the cytoplasm of the hepatocyte, displacing the nucleus to the periphery [1]. This is the hallmark of chronic conditions like Alcohol-associated Liver Disease (ALD), Obesity, and Diabetes Mellitus (NAFLD) [3, 4]. In contrast, **microvesicular steatosis** is characterized by the accumulation of multiple tiny fat droplets within the cytoplasm that do not displace the nucleus. This pattern is usually associated with acute, severe mitochondrial dysfunction and impaired beta-oxidation of fatty acids. **Analysis of Incorrect Options:** * **Tetracycline toxicity:** High doses of intravenous tetracycline (especially in pregnant women) cause direct mitochondrial injury leading to microvesicular fat. * **Acute fatty liver of pregnancy (AFLP):** A life-threatening third-trimester emergency often associated with a deficiency of the enzyme Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) in the fetus, resulting in microvesicular changes. * **Reye’s Syndrome:** Occurs in children following a viral illness (Influenza/Varicella) treated with Aspirin. It causes profound mitochondrial damage and microvesicular steatosis. **High-Yield Clinical Pearls for NEET-PG:** * **Macrovesicular Steatosis:** Alcohol, Obesity, Diabetes, Malnutrition (Kwashiorkor), and Hepatitis C (Genotype 3) [4, 5]. * **Microvesicular Steatosis:** Reye’s Syndrome, AFLP, Tetracyclines, Sodium Valproate toxicity, and Jamaican Vomiting Sickness. * **Key Histology:** In microvesicular steatosis, the hepatocyte looks "foamy" or "clear," but the nucleus remains central. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 848-850. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 852-854. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 388-389.

Question 236: Emperioplosis is seen in which of the following conditions?

A. Alcoholic hepatitis
B. Acute hepatitis
C. Chronic hepatitis
D. Autoimmune hepatitis (Correct Answer)

Explanation: **Explanation:** **Emperipolesis** is a characteristic histological feature of **Autoimmune Hepatitis (AIH)**. It refers to the active penetration of one cell into the cytoplasm of another cell, where both remain viable [1]. In the context of AIH, it specifically describes **CD8+ T-lymphocytes or Plasma cells** being engulfed by **Hepatocytes**. 1. **Why Autoimmune Hepatitis is correct:** AIH is characterized by a dense portal inflammatory infiltrate. The hallmark histological triad includes: * **Interface Hepatitis:** Inflammation spilling from the portal tract into the parenchyma [1]. * **Plasma cell-rich infiltrates:** Predominance of plasma cells in the portal areas [1]. * **Emperipolesis:** Lymphocytes seen within the cytoplasm of hepatocytes, often associated with hepatocyte apoptosis and "rosette" formation [1]. 2. **Why other options are incorrect:** * **Alcoholic Hepatitis:** Characterized by **Mallory-Denk bodies** (ubiquitinated keratin filaments), neutrophil infiltration, and "chicken-wire" fibrosis [3]. * **Acute Hepatitis:** Typically shows spotty necrosis, ballooning degeneration, and Acidophil (Councilman) bodies, but lacks the specific emperipolesis seen in AIH [2]. * **Chronic Hepatitis (Viral):** While it shares interface hepatitis with AIH, it is distinguished by specific markers (e.g., **Ground-glass hepatocytes** in HBV or lymphoid aggregates in HCV [4]) rather than emperipolesis. **High-Yield Clinical Pearls for NEET-PG:** * **Serology:** AIH Type 1 is associated with **ANA** and **Anti-Smooth Muscle Antibodies (ASMA)**; Type 2 is associated with **Anti-LKM1** antibodies [1]. * **Other conditions with Emperipolesis:** Rosai-Dorfman disease (histiocytes engulfing lymphocytes) and Giant Cell Arteritis. * **Liver Rosettes:** In AIH, regenerating hepatocytes form clusters called "rosettes" as a response to severe injury [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 844-846. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 386-387. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 389-390. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 844-845.

Question 237: Which of the following statements about fibrolamellar hepatocellular carcinoma is FALSE?

A. It is associated with cirrhosis. (Correct Answer)
B. Recurrences are seen despite a better prognosis.
C. There is an increase in neurotensin and vitamin B12 binding factors.
D. Lymph node metastasis is seen.

Explanation: **Explanation:** Fibrolamellar Hepatocellular Carcinoma (FL-HCC) is a distinct variant of hepatocellular carcinoma that differs significantly from the conventional type in its epidemiology and pathogenesis. **1. Why Option A is the Correct Answer (The False Statement):** Unlike conventional HCC, which typically arises in the background of chronic liver disease or cirrhosis (due to HBV, HCV, or alcohol), **FL-HCC occurs in non-cirrhotic livers.** It typically affects young adults (20–40 years) with no gender predilection and no association with viral hepatitis or metabolic syndrome [1]. **2. Analysis of Other Options:** * **Option B:** FL-HCC generally has a **better prognosis** than conventional HCC because it occurs in a healthy liver, allowing for more aggressive surgical resection [1]. However, the rate of **recurrence** remains high even after successful surgery. * **Option C:** A high-yield biochemical marker for FL-HCC is a significant elevation in **serum neurotensin** and **Vitamin B12-binding capacity** (transcobalamin I). Unlike conventional HCC, Serum Alpha-Fetoprotein (AFP) is usually normal [1]. * **Option D:** FL-HCC has a high propensity for **lymph node metastasis**, which is often present at the time of diagnosis. **NEET-PG High-Yield Pearls:** * **Morphology:** Characterized by large, polygonal cells with abundant eosinophilic cytoplasm (oncocytic) and prominent nucleoli, separated by **parallel lamellae of collagen bundles**. * **Molecular Marker:** The most specific genetic finding is a recurrent **DNAJB1-PRKACA gene fusion**. * **Imaging:** Often presents as a large solitary mass with a **central stellate scar** (must be differentiated from Focal Nodular Hyperplasia). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400.

Question 238: Which cells produce collagen in cirrhosis?

A. Perisinusoidal cell (stellate cell) (Correct Answer)
B. Kupffer cell
C. Hepatocyte
D. Dendritic cell

Explanation: **Explanation:** The central mechanism of cirrhosis is **fibrosis**, which involves the excessive deposition of Type I and Type III collagen in the Space of Disse. **1. Why Option A is correct:** The **Perisinusoidal cells (Stellate cells or Ito cells)** are the primary source of collagen in cirrhosis. In a healthy liver, these cells are quiescent and function to store Vitamin A. However, in response to chronic liver injury, they undergo "activation." [1], [2] Triggered by cytokines like **TGF-β** (the most potent fibrogenic cytokine), PDGF, and TNF, they transform into **myofibroblast-like cells**. These activated cells lose their Vitamin A droplets and begin synthesizing large amounts of extracellular matrix (ECM) and collagen, leading to fibrosis. [1] **2. Why the other options are incorrect:** * **Kupffer cells (Option B):** These are specialized macrophages located within the sinusoids. [1] While they play a crucial role by secreting the cytokines (like TGF-β) that *activate* stellate cells, they do not produce collagen themselves. * **Hepatocytes (Option C):** These are the functional parenchymal cells of the liver. In cirrhosis, they undergo necrosis or apoptosis; they do not transform into collagen-producing cells. * **Dendritic cells (Option D):** These are antigen-presenting cells involved in the immune response and do not have a role in the structural deposition of collagen. **High-Yield NEET-PG Pearls:** * **Space of Disse:** The anatomical location where stellate cells reside and where collagen deposition begins (leading to "capillarization" of sinusoids). * **TGF-β:** The most important cytokine involved in the activation of stellate cells. * **Vitamin A Storage:** Quiescent stellate cells are the body's primary storage site for Vitamin A (retinoids). * **Morphology:** Cirrhosis is characterized by the triad of bridging fibrosis, regenerating nodules, and disruption of the entire liver architecture. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 381-382. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 830-832.

Question 239: Which of the following is NOT a tumor marker for primary hepatocellular carcinoma?

A. Alpha-fetoprotein
B. Alpha-2 macroglobulin (Correct Answer)
C. PIVKA-2
D. Neurotensin

Explanation: **Explanation:** The diagnosis of Hepatocellular Carcinoma (HCC) often relies on a combination of imaging and specific serum biomarkers. **Why Alpha-2 macroglobulin is the correct answer:** Alpha-2 macroglobulin is a large plasma glycoprotein produced by the liver that acts as an antiprotease. While its levels may fluctuate in various chronic liver diseases (like cirrhosis or fibrosis), it is **not** a specific tumor marker for HCC. In fact, decreased levels are sometimes noted in advanced liver disease due to impaired synthesis. **Analysis of incorrect options (True HCC markers):** * **Alpha-fetoprotein (AFP):** The most widely used screening and diagnostic marker for HCC [1]. Levels >200 ng/mL in a patient with a liver mass are highly suggestive of HCC [2]. * **PIVKA-2 (Protein Induced by Vitamin K Absence/Antagonist-II):** Also known as Des-gamma-carboxyprothrombin (DCP). It is an abnormal prothrombin molecule produced by malignant hepatocytes. It is highly specific for HCC and often used in conjunction with AFP to increase diagnostic sensitivity. * **Neurotensin:** This is a neuropeptide that is frequently elevated in patients with **Fibrolamellar variant of HCC**, making it a recognized biochemical marker for this specific subtype. **NEET-PG High-Yield Pearls:** * **Fibrolamellar HCC:** Characterized by normal AFP levels, elevated **Neurotensin**, and elevated **Vitamin B12 binding capacity**. * **AFP-L3:** A glycoform of AFP that is more specific for HCC than total AFP; it helps differentiate HCC from benign chronic liver disease. * **Glypican-3:** A cell-surface heparan sulfate proteoglycan that is a highly sensitive immunohistochemical (IHC) marker for HCC. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 399-400. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 346.

Question 240: Which of the following is NOT a metabolic cause of liver disease?

A. Histiocytosis (Correct Answer)
B. Hemochromatosis
C. Gaucher's disease
D. Wilson's disease

Explanation: **Explanation:** The correct answer is **Histiocytosis (Option A)**. **Why Histiocytosis is the correct answer:** Histiocytosis (specifically Langerhans Cell Histiocytosis) is categorized as a **neoplastic/proliferative disorder** involving dendritic cells, rather than a primary metabolic defect. While it can involve the liver—leading to hepatomegaly, jaundice, or sclerosing cholangitis-like patterns—the underlying pathology is an abnormal proliferation of cells, not a systemic error of metabolism. **Analysis of Incorrect Options (Metabolic Causes):** * **Hemochromatosis (Option B):** An autosomal recessive disorder of **iron metabolism** [1] leading to excessive iron deposition in hepatocytes, eventually causing micronodular cirrhosis and increasing the risk of hepatocellular carcinoma [4]. * **Gaucher’s Disease (Option C):** A **lysosomal storage disorder** caused by a deficiency of glucocerebrosidase. This leads to the accumulation of glucosylceramide in macrophages (Gaucher cells) within the liver and spleen [1], making it a classic metabolic cause of hepatomegaly. * **Wilson’s Disease (Option D):** An autosomal recessive disorder of **copper metabolism** (ATP7B mutation) [3]. Impaired biliary excretion of copper leads to toxic accumulation in the liver, brain (basal ganglia), and eyes (Kayser-Fleischer rings) [2]. **NEET-PG High-Yield Pearls:** * **Gaucher Cells:** Described as having a "crinkled paper" or "wrinkled tissue paper" appearance of the cytoplasm. * **Hemochromatosis Triad:** "Bronze Diabetes" (Cirrhosis, Diabetes Mellitus, and Skin Hyperpigmentation). * **Wilson’s Disease Screening:** Low serum ceruloplasmin levels and increased 24-hour urinary copper excretion [2], [3]. * **Histiocytosis Marker:** Positive for **S100, CD1a, and Langerin (CD207)**; electron microscopy shows **Birbeck granules** (tennis-racket shape). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 393-394. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 394-395. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 855-856. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 854-855.

Practice by Chapter

Jaundice and Cholestasis

Practice Questions

Viral Hepatitis

Practice Questions

Alcoholic and Non-alcoholic Fatty Liver Disease

Practice Questions

Drug and Toxin Induced Liver Injury

Practice Questions

Cirrhosis and Its Complications

Practice Questions

Metabolic Liver Diseases

Practice Questions

Liver Tumors

Practice Questions

Gallbladder and Biliary Tract Diseases

Practice Questions

Congenital Liver Diseases

Practice Questions

Liver Transplantation Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free